Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Patent
1997-01-24
1999-11-16
Spivack, Phyllis G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
514428, 514317, 514212, A61K 31135, A61K 3140, A61K 31445, A61K 3155
Patent
active
059859334
ABSTRACT:
Methods of treating painful neuropathies are provided comprising administering compounds comprising the (S)-isomer of chiral compounds having the formula: ##STR1## wherein R1 is C1-C5 hydrocarbyl, R2 and R3 are independently C1-C5 hydrocarbyl or H, R4 is C1-C5 hydrocarbyl, R3 and R4 may optionally be joined together to form a 5, 6 or 7 membered ring system, or a pharmaceutically acceptable salt thereof, substantially free of the (R)-isomer.
REFERENCES:
patent: 3954872 (1976-05-01), Koppe et al.
Ackerman, III, et al., "The Management fo Oral Mexiletine and Intravenous Lidocaine to Treat Chronic Painful Symmetrical Distal Diabetic Neuropathy", KMA J., 1991, 89, 500-501.
Awerbuch et al., "Mexiletine for thalamic pain syndrome", Internal J. Neuroscience, 1990, 55, 129-133.
Backonja, "Local Anesthetics as Adjuvant Analgesics", J. Pain Sympt. Man., 1994, 9(8), 491-499.
Calcutt et al., "Impaired induction of vasoactive intestinal polypeptide after sciatic nerve injury in the streptozotocin-diabetic rat", J. Neurol. Sci., 1993, 119, 154-160.
Campbell, "Mexiletine", New Eng. J. Med., 1987, 316(1), 29-34.
Chabal et al., "The use of oral mexiletine for the treatment of pain after peripheral nerve injury", Anesthesiology, 1992, 76, 513-517.
Chaplan, S.R. et al., "Quantitative assessment of allodynia in the rat paw", J. Neurosci. Methods, 1994, 53, 55-63.
Chaplan et al., "Prolonged alleviation of tactile allodynia by intravenous lidocaine in neuropathic rats", Anesthesiology, 1995, 83, 775-785.
Courteix et al., "Study of the sensitivity of the diabetes-induced pain model in rats to a range of analgesics", Pain, 1994, 57, 153-160.
Colclough et al., "Mexiletine for chronic pain", Lancet, 1993, 342, 1484-1485.
Dejgard et al., "Mexiletine for treatment of chronic painful diabetic neuropathy", Lancet, 1988, 2, 9-11.
Franchini et al., "Stereoselectivity in Central Analgesic Action of Tocainide and Its Analogs", Chirality, 1993, 5, 135-142.
Grech-Belanger et al., "Stereoselective disposition of mexiletine in man", Br. J. Clin. Pharmacol., 1986, 21, 481-487.
Greenwald et al., "The prevalence of pain in four cancers", Cancer, 1987, 60, 2563-2569.
Harbilas, "Mexiletine for Pain?", Hos. Pharm., 1995, 30, 720 and 723.
Hardman, J.G. (ed.), Goodman & Gilman's The Pharmacological Basis of Therapeutics, 9th ed., McGraw-Hill, 1996, p. 219.
Hill et al., "Determinants of stereospecific binding of Type I antiarrhythmic drugs to cardiac sodium channels", Molec. Pharmacol., 1988, 34, 659-663.
Kalichman et al., "Local anesthetic-induced conduction block and nerve fiber injury in streptozotocin-diabetic rats", Anesthesiology, 1992, 77, 941-947.
Kamei et al., "Antinociceptive effect of mexilitene in diabetic mice", Res. Commun. Chem. Pathol. Pharmacol., 1992, 77, 245-248.
Kastrup, "Clinical Note: Intravenous lidocaine infusion--a new treatment of chronic painful diabetic neuropathy?", Pain, 1987, 28, 69-75.
Kim et al., "An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat", Pain, 1992, 50, 355-363.
Kreeger et al., "New Antiarrhythmic Drugs: Tocainide, Meiletine, Flecainide, Encainide, and Amiodarone", Mayo Clin. Proc., 1987, 62, 1033-1050.
Kubota et al., "Relief of severe diabetic truncal pain with mexiletine", J. Med., 1991, 22(4 & 5), 307-310.
Kwok et al., "Pharmacokinetics of mexiletine enantiomers in healthy subjects. A study of the in vivo serum protein binding, salivary excretion and red blood cell distribution of the enantiomers", Xenobiotica, 1995 25(10):1127-1142.
Lindstrom et al., "The analgesic effect of tocainide in trigeminal neuralgia", Pain, 1987, 28, 45-50.
Marchettini et al., "Lidocaine test in neuralgia", Pain, 1992, 48, 377-382.
Monk et al., "Mexiletine: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in the treatment of arrhythmias", Drugs, 1990, 40(3), 374-411.
Nishiyama et al., "Mexiletine for painful alcoholic neuropathy", Internal Medicine, 1995, 34(6), 577-579.
Paggioli et al., "Intravenous and Oral Anesthetics in Pain Management: Reflections on Intravenous Lidocaine and Mexiletine", Pain Digest, 1995, 5, 69-72.
Pfeifer et al., "A highly successful and novel method for treatment of chronic painful diabetic peripheral neuropathy", Diabetes Care, 1993, 16(8), 1103-1115.
Petersen et al., "Chronic pain treatment with intravenous lidocaine", Neurological Research, 1986, 8, 189-190.
Portenoy, "Pharmacologic approaches to the control of cancer pain", J. Psychosoc. Oncol., 1990, 8, 2-3 and 75-107.
Stracke et al., "Mexitetine in the Treatment of Diabetic Neuropathy", Diabetes Care, 1992, 15(11), 1550-1555.
Tanelian et al., "Neuropathic pain can be relieved by drugs that are use-dependent sodium channel blockers: lidocaine, carbmazepine, and mexiletine", Anesthesiology, 1991, 74, 949-951.
Turgeon et al., "Resolution and electrophysiological effects of mexiletine enantiomers", J. Pharm. Pharmacol., 1991, 43, 630-635.
Wilkie, "Cancer pain management: State-of-the-art nursing care", Nurs. Clin. North Am., 1990, 25(2), 331-343.
Xu et al., "Systemic mexiletine relieves chronic allodynia-like symptoms in rats with ischemic spinal cord injury", Anesth. Analg., 1992, 74, 649-652.
Yaksh et al., "The spinal pharmacology of facilitation of afferent processing evoked by high-threshold afferent input of the postinjury pain state", Curr. Opin. Neurol. Neurosurgery, 1993, 6, 250-256.
Vozeh et al., "Population pharmacokinetic parameters in patients treated with oral mexiletene", Eur. J. Clin. Pharmacol., 1982, 23, 445-451.
Celgene Corporation
Spivack Phyllis G.
LandOfFree
Methods for treating central and peripheral nerve pain does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for treating central and peripheral nerve pain, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for treating central and peripheral nerve pain will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1325397